Medpace (MEDP) Stock: Why It Moved Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $619.66, +0.19% vs the prior close of $618.47.
- Volume 233.70K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MEDP ends flat (+0.2%) to $619.66. Closed at $619.66, +0.19% vs the prior close of $618.47. Day range $616.14–$625.69, opened at $619.33.
MEDP daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — MEDP ends flat (+0.2%) to $619.66
- Closed at $619.66, +0.19% vs the prior close of $618.47. Day range $616.14–$625.69, opened at $619.33.
- Volume was 233.70K shares, 1.0x its 50-day average of 230.02K.
- Price is +2.1% vs its 50-day average ($606.98) and +17.7% vs its 200-day average ($526.46).
- 52-week range $373.00–$677.90; today's close sits at 81% of that range, 8.6% below the 52-week high.
Oct 16, 2026 — MEDP dips 1.6% to $618.47
- Closed at $618.47, -1.61% vs the prior close of $628.60. Day range $610.05–$632.33, opened at $630.29.
- Volume was 297.57K shares, 1.3x its 50-day average of 226.49K.
- Price is +2.0% vs its 50-day average ($606.40) and +17.5% vs its 200-day average ($526.17).
- 52-week range $373.00–$677.90; today's close sits at 81% of that range, 8.8% below the 52-week high.
Oct 15, 2026 — MEDP rises 1.9% to $628.60
- Closed at $628.60, +1.94% vs the prior close of $616.63. Day range $617.60–$635.31, opened at $622.83.
- Volume was 391.80K shares, 1.8x its 50-day average of 223.58K.
- Price is +3.8% vs its 50-day average ($605.73) and +19.5% vs its 200-day average ($525.93).
- 52-week range $373.00–$677.90; today's close sits at 84% of that range, 7.3% below the 52-week high.
Oct 14, 2026 — MEDP rises 1.1% to $616.63
- Closed at $616.63, +1.11% vs the prior close of $609.89. Day range $605.76–$630.88, opened at $605.76.
- Volume was 311.20K shares, 1.4x its 50-day average of 221.92K.
- Price is +1.9% vs its 50-day average ($604.91) and +17.3% vs its 200-day average ($525.63).
- 52-week range $373.00–$677.90; today's close sits at 80% of that range, 9.0% below the 52-week high.
Oct 13, 2026 — MEDP dips 1.6% to $609.89
- Closed at $609.89, -1.64% vs the prior close of $620.05. Day range $609.48–$620.76, opened at $620.05.
- Volume was 155.30K shares, 0.7x its 50-day average of 223.80K.
- Price is +1.0% vs its 50-day average ($604.08) and +16.1% vs its 200-day average ($525.39).
- 52-week range $373.00–$677.90; today's close sits at 78% of that range, 10.0% below the 52-week high.
Oct 12, 2026 — MEDP rises 1.3% to $620.05
- Closed at $620.05, +1.31% vs the prior close of $612.05. Day range $608.71–$623.11, opened at $612.70.
- Volume was 176.20K shares, 0.8x its 50-day average of 225.50K.
- Price is +2.8% vs its 50-day average ($603.35) and +18.1% vs its 200-day average ($525.20).
- 52-week range $373.00–$677.90; today's close sits at 81% of that range, 8.5% below the 52-week high.
Oct 9, 2026 — MEDP rises 1.6% to $612.05
- Closed at $612.05, +1.55% vs the prior close of $602.70. Day range $602.70–$620.25, opened at $602.70.
- Volume was 159.80K shares, 0.7x its 50-day average of 228.67K.
- Price is +1.6% vs its 50-day average ($602.49) and +16.6% vs its 200-day average ($524.95).
- 52-week range $373.00–$677.90; today's close sits at 78% of that range, 9.7% below the 52-week high.
Oct 8, 2026 — MEDP ends flat (-0.3%) to $602.70
- Closed at $602.70, -0.26% vs the prior close of $604.25. Day range $590.46–$604.56, opened at $602.43.
- Volume was 223.10K shares, 0.9x its 50-day average of 235.83K.
- Price is +0.1% vs its 50-day average ($601.82) and +14.9% vs its 200-day average ($524.74).
- 52-week range $373.00–$677.90; today's close sits at 75% of that range, 11.1% below the 52-week high.
Oct 7, 2026 — MEDP ends flat (+0.2%) to $604.25
- Closed at $604.25, +0.22% vs the prior close of $602.90. Day range $596.08–$615.63, opened at $600.00.
- Volume was 207.60K shares, 0.8x its 50-day average of 246.56K.
- Price is +0.5% vs its 50-day average ($601.46) and +15.2% vs its 200-day average ($524.57).
- 52-week range $373.00–$677.90; today's close sits at 76% of that range, 10.9% below the 52-week high.
Oct 6, 2026 — MEDP dips 2.8% to $602.90
- Closed at $602.90, -2.84% vs the prior close of $620.51. Day range $601.36–$642.65, opened at $624.86.
- Volume was 219.10K shares, 0.9x its 50-day average of 250.49K.
- Price is +0.4% vs its 50-day average ($600.79) and +15.0% vs its 200-day average ($524.35).
- 52-week range $373.00–$677.90; today's close sits at 75% of that range, 11.1% below the 52-week high.
Oct 5, 2026 — MEDP jumps 3.5% to $620.51
- Closed at $620.51, +3.51% vs the prior close of $599.47. Day range $601.94–$623.97, opened at $601.94.
- Volume was 341.20K shares, 1.3x its 50-day average of 253.51K.
- Price is +3.3% vs its 50-day average ($600.52) and +18.4% vs its 200-day average ($524.12).
- 52-week range $373.00–$677.90; today's close sits at 81% of that range, 8.5% below the 52-week high.
Oct 2, 2026 — MEDP ends flat (+0.2%) to $599.47
- Closed at $599.47, +0.23% vs the prior close of $598.08. Day range $587.39–$609.75, opened at $593.03.
- Volume was 303.70K shares, 1.1x its 50-day average of 270.98K.
- Price is -0.1% vs its 50-day average ($600.14) and +14.4% vs its 200-day average ($523.81).
- 52-week range $373.00–$677.90; today's close sits at 74% of that range, 11.6% below the 52-week high.
MEDP bull case vs bear case (from the data)
- Price is +2.1% vs its 50-day average — short-term trend is up.
- Price is +17.7% vs its 200-day average — above the long-term trend line.
- Annual revenue grew 20.0% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: profit of $451.12M.
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
MEDP latest news & SEC filings
Every SEC filing by or about MEDP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Burwig Susan E converted options/RSUs into 3,000 shares at $166.73 (≈$500.19K) on Oct 12, 2026; now holds 70,984
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Burwig Susan E converted options/RSUs into 2,000 shares at $166.73 (≈$333.46K) on Oct 7, 2026; now holds 67,984
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mccarthy Cornelius P. Iii converted options/RSUs into 28 shares on Sep 30, 2026; now holds 12,303
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kraft Robert O. converted options/RSUs into 32 shares on Sep 30, 2026; now holds 987
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Carley Brian T converted options/RSUs into 36 shares on Sep 30, 2026; now holds 27,861
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Troendle August J. sold 26,701 shares at $621.02 (≈$16.58M) on Sep 29, 2026; now holds 360,191
- Troendle August J. sold 21,966 shares at $625.47 (≈$13.74M) on Sep 30, 2026; now holds 338,225
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 23, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $707.33M (prior year $603.31M) (+17.2% vs Jun 30, 2025)
- Net income: $121.36M (prior year $90.26M) (+34.5% vs Jun 30, 2025)
- Diluted EPS: $4.25 (prior year $3.10) (+37.1% vs Jun 30, 2025)
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade MEDP
- Last results release: Jul 22, 2026 (8-K Item 2.02). Previous ones: Apr 22, 2026, Feb 9, 2026, Oct 22, 2025. Based on that rhythm, the next report is likely around Oct 21, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.31% (largest 4.2%).
- Liquidity: about 259.69K shares (≈$160.92M) trade per day on average.
- 52-week position: $619.66 vs a range of $373.00–$677.90 (81% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: August J. Troendle sold 2,410 shares on Sep 28, 2026.
- Latest filings: 10-Q Jul 23, 2026; 8-K Jul 22, 2026; 8-K Jun 4, 2026.
- Share count: 27.91M shares outstanding (Jul 17, 2026), -0.6% vs a year earlier.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
MEDP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 619.33 | 625.69 | 616.14 | 619.66 | 233.70K |
| Oct 16, 2026 | 630.29 | 632.33 | 610.05 | 618.47 | 325.10K |
| Oct 15, 2026 | 622.83 | 635.31 | 617.60 | 628.60 | 391.80K |
| Oct 14, 2026 | 605.76 | 630.88 | 605.76 | 616.63 | 311.20K |
| Oct 13, 2026 | 620.05 | 620.76 | 609.48 | 609.89 | 155.30K |
| Oct 12, 2026 | 612.70 | 623.11 | 608.71 | 620.05 | 176.20K |
| Oct 9, 2026 | 602.70 | 620.25 | 602.70 | 612.05 | 159.80K |
| Oct 8, 2026 | 602.43 | 604.56 | 590.46 | 602.70 | 223.10K |
| Oct 7, 2026 | 600.00 | 615.63 | 596.08 | 604.25 | 207.60K |
| Oct 6, 2026 | 624.86 | 642.65 | 601.36 | 602.90 | 219.10K |
| Oct 5, 2026 | 601.94 | 623.97 | 601.94 | 620.51 | 341.20K |
| Oct 2, 2026 | 593.03 | 609.75 | 587.39 | 599.47 | 303.70K |
| Oct 1, 2026 | 627.47 | 628.60 | 597.37 | 598.08 | 233.40K |
| Sep 30, 2026 | 622.60 | 628.69 | 614.30 | 624.18 | 306.60K |
| Sep 29, 2026 | 612.25 | 622.70 | 610.06 | 622.11 | 250.70K |
| Sep 28, 2026 | 616.16 | 621.62 | 608.05 | 615.94 | 238.70K |
| Sep 25, 2026 | 620.60 | 620.60 | 608.11 | 618.88 | 229.10K |
| Sep 24, 2026 | 612.30 | 626.83 | 610.79 | 620.59 | 308.80K |
| Sep 23, 2026 | 630.06 | 637.65 | 614.18 | 617.15 | 275.70K |
| Sep 22, 2026 | 624.02 | 632.72 | 619.62 | 630.19 | 303.00K |
About Medpace
Medpace (MEDP) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in CINCINNATI, OH. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1668397.
MEDP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Brian T Carley | Director | Aug 21, 2026 |
| Fred B Jr Davenport | Director | Aug 21, 2026 |
| Femida H. Gwadry-Sridhar | Director | May 18, 2026 |
| Robert O. Kraft | Director | Aug 28, 2026 |
| Cornelius P. Iii Mccarthy | Director | Aug 13, 2026 |
| August J. Troendle | President & CEO | Sep 29, 2026 |
| Dani S. Zander | Director | May 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Susan E Burwig | Exec. VP, Operations | Sep 17, 2026 |
| Kevin M. Brady | CFO & Treasurer | Aug 24, 2026 |
| Stephen P Ewald | General Counsel & Corp. Secy. | Jun 1, 2026 |
| Jesse J Geiger | President | Mar 19, 2026 |
| Brad W. Hansman | Exec. VP, Operations | Jun 4, 2026 |
| August J. Troendle | President & CEO | Sep 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | August J. Troendle | Sale | 2,410 | $620.07 |
| Sep 28, 2026 | August J. Troendle | Sale | 2,410 | $620.07 |
| Sep 28, 2026 | August J. Troendle | Sale | 2,410 | $620.07 |
| Sep 28, 2026 | August J. Troendle | Sale | 2,410 | $620.07 |
| Sep 25, 2026 | August J. Troendle | Sale | 154 | $620.60 |
| Sep 25, 2026 | August J. Troendle | Sale | 154 | $620.60 |
| Sep 25, 2026 | August J. Troendle | Sale | 154 | $620.60 |
| Sep 25, 2026 | August J. Troendle | Sale | 154 | $620.60 |
| Sep 24, 2026 | August J. Troendle | Sale | 27,833 | $621.33 |
| Sep 24, 2026 | August J. Troendle | Sale | 27,833 | $621.33 |
| Sep 24, 2026 | August J. Troendle | Sale | 27,833 | $621.33 |
| Sep 24, 2026 | August J. Troendle | Sale | 27,833 | $621.33 |
| Sep 23, 2026 | August J. Troendle | Sale | 16,083 | $628.64 |
| Sep 23, 2026 | August J. Troendle | Sale | 16,083 | $628.64 |
| Sep 23, 2026 | August J. Troendle | Sale | 16,083 | $628.64 |
MEDP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.53B | $451.12M | 15.28 | $713.22M |
| Dec 31, 2024 | $2.11B | $404.39M | 12.63 | $608.82M |
| Dec 31, 2023 | $1.89B | $282.81M | 8.88 | $433.37M |
| Dec 31, 2022 | $1.46B | $245.37M | 7.28 | $388.05M |
| Dec 31, 2021 | $1.14B | $181.85M | 4.81 | $263.33M |
Latest balance sheet: total assets $2.06B, total liabilities $1.62B, cash $502.69M (as of Jun 30, 2026).
MEDP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 22, 2026 | 8-K Item 2.02 (results) | $528.12 |
| Apr 22, 2026 | 8-K Item 2.02 (results) | $508.46 |
| Feb 9, 2026 | 8-K Item 2.02 (results) | $530.35 |
| Oct 22, 2025 | 8-K Item 2.02 (results) | $546.74 |
| Jul 21, 2025 | 8-K Item 2.02 (results) | $308.88 |
| Apr 21, 2025 | 8-K Item 2.02 (results) | $288.99 |
| Feb 10, 2025 | 8-K Item 2.02 (results) | $354.51 |
| Oct 21, 2024 | 8-K Item 2.02 (results) | $352.92 |
| Jul 22, 2024 | 8-K Item 2.02 (results) | — |
| Apr 22, 2024 | 8-K Item 2.02 (results) | — |
| Feb 12, 2024 | 8-K Item 2.02 (results) | — |
| Oct 23, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Icon (ICLR)Absci (ABSI)bioAffinity Technologies (BIAF)OmniAb (OABI)Nrc Health (NRC)Maxcyte (MXCT)iSpecimen (ISPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on MEDP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.